filmov
tv
ZIRCON trial and diagnosis ccRCC
Показать описание
In this interview, Dr. Patricia Zondervan (NL) talks to our chief editor Dr. Carmen Mir (ES) about the ZIRCON trial results and the role of girentuximab in decision-making.
European Association of Urology
kidney cancer
zircon trial
oncology
Рекомендации по теме
0:06:09
ZIRCON trial and diagnosis ccRCC
0:02:17
ZIRCON Phase III Study of TLX250-CDx in Clear Cell Renal Cell Carcinoma (ccRCC)
0:02:17
ZIRCO: 89Zr-DFO-girentuximab for PET/CT imaging of clear cell renal cell carcinoma
0:13:52
Kidney cancer - Take home messages for 2024
0:04:44
STARLITE 2 study
0:02:15
Kidney cancer at ASCO GU: PAPMET & CLEAR
0:04:36
Safety Considerations for 89Zr-girentuximab PET/CT Imaging in ccRCC
0:20:39
Kidney Cancer Conference Highlights from ASCO GU 2023
1:05:10
UROwebinar: Next generation imaging in renal cancer
0:01:06
Key trials in kidney cancer at ASCO GU 2023
0:00:43
Hot topics in RCC at ASCO GU 2023
0:17:58
Novel Imaging for Renal Mass Characterization
0:00:48
Are you a renal cell carcinoma warrior? #renalcellcarcinoma #raredisease #rarediseaseawareness #fin
0:03:13
Is systemic therapy impactful for Renal Cell Carcinoma? An interview with Prof. Börje Ljungberg
0:05:16
Telix – Delivering on the promise of precision medicine through targeted radiation.
0:14:32
New Perspectives in Prostate and Kidney Cancer - Laura Ravasi, MD PhD
0:03:16
Synthesis, preclinical analysis, and first-inhuman phase I imaging of 89Zr-DFOdaratumumab for CD...
0:11:37
Dr Santosh Kumar C | 2nd Line options in Renal Cell Cancer
0:10:54
Dr Santosh Kumar | C 2nd Line options in renal Cell cancer
0:01:13
Renal Cell Carcinoma RCC Kidney Cancer with metastasis responded by Dr Arpit Chopra ModernHomeopathy
0:46:47
Keynote Presentation: Advanced Imaging for Small Renal Tumors
1:04:50
Discover Science: Advances in Radiopharmaceuticals to Diagnose and Treat Diseases
0:23:22
Biotech Unlocked - TELIX PHARMACEUTICALS ASX:TLX
0:17:33
ASX CEO Connect April 2022 - Telix Pharmaceuticals Limited (ASX: TLX)